Amylyx

Focus: Neurodegenerative diseases, amyotrophic lateral sclerosis (ALS), Alzheimer’s disease, Wolfram syndrome

Amylyx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases.

Pharmaceuticals